Cytochrome p450: What have we learned and what are the future issues?

被引:166
作者
Guengerich, FP
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
关键词
cytochrome p450; ligand binding; catalytic cycle; isotope effects; polymorphism;
D O I
10.1081/DMR-120033996
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cytochrome P450 (P450) field came out of interest in the metabolism of drugs, carcinogens, and steroids, which remain major focal points. Over the years we have come to understand the P450 system components, the multiplicity of P450s, and many aspects of the regulation of the genes and also the catalytic mechanism. Many crystal structures are now becoming available. The significance of P450 in in vivo metabolism is appreciated, particularly in the context of pharmacogenetics. Current scientific issues involve posttranslational modification, gene regulation, component interactions, structures of P450 complexed with ligands, details of high-valent oxygen chemistry, the nature and influence of rate-limiting steps, greater details about some reaction steps, cooperativity, and the relevance of P450 variations to cancer risk. Some emerging research areas involve new methods of analysis of ligand interactions, roles of conformational changes linked to individual reaction steps, functions of orphan P450s, "molecular breeding" of new P450 functions and enhanced activity, and the utilization of P450s in chemical synthesis.
引用
收藏
页码:159 / 197
页数:39
相关论文
共 221 条
  • [1] MECHANISM OF THE ACYL-CARBON CLEAVAGE AND RELATED REACTIONS CATALYZED BY MULTIFUNCTIONAL P-450S - STUDIES ON CYTOCHROME-P-450(17-ALPHA)
    AKHTAR, M
    CORINA, D
    MILLER, S
    SHYADEHI, AZ
    WRIGHT, JN
    [J]. BIOCHEMISTRY, 1994, 33 (14) : 4410 - 4418
  • [2] Aldridge S, 2003, GENET ENG NEWS, V23, P76
  • [3] Interaction of adrenodoxin with P4501A1 and its truncated form P450MT2 through different domains: Differential modulation of enzyme activities
    Anandatheerthavarada, HK
    Addya, S
    Mullick, J
    Avadhani, NG
    [J]. BIOCHEMISTRY, 1998, 37 (04) : 1150 - 1160
  • [4] ENHANCEMENT AND INHIBITION OF DRUG METABOLISM
    ANDERS, MW
    [J]. ANNUAL REVIEW OF PHARMACOLOGY, 1971, 11 : 37 - &
  • [5] Ariyoshi N, 2002, CANCER EPIDEM BIOMAR, V11, P890
  • [6] ARMSTRONG RN, 1983, J BIOL CHEM, V258, P2106
  • [7] Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer
    Auchus, RJ
    Lee, TC
    Miller, WL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) : 3158 - 3165
  • [8] Revisiting the mechanism of P450 enzymes with the radical clocks norcarane and spiro[2,5]octane
    Auclair, K
    Hu, ZB
    Little, DM
    de Montellano, PRO
    Groves, JT
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (21) : 6020 - 6027
  • [9] EVIDENCE FOR SUPEROXIDE GENERATION BY NADPH-CYTOCHROME-C REDUCTASE OF RAT-LIVER MICROSOMES
    AUST, SD
    ROERIG, DL
    PEDERSON, TC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 47 (05) : 1133 - &
  • [10] AXELROD JULIUS, 1955, JOUR BIOL CHEM, V214, P753